Literature DB >> 11723294

Apolipoprotein E and age at onset of Alzheimer's disease in African American patients.

F C Goldstein1, A V Ashley, M Gearing, J Hanfelt, L Penix, L J Freedman, A I Levey.   

Abstract

The authors examined whether the APOE-epsilon4 allele is associated with an earlier age at onset of AD in 71 African American patients with probable AD. The authors found a linear dose effect in which each copy of the epsilon4 allele was associated with a 3.6-year earlier onset of AD, indicating a dose-dependent relationship between APOE-epsilon4 and age at onset of AD in African Americans.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11723294     DOI: 10.1212/wnl.57.10.1923

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  5 in total

Review 1.  Neuropsychological differences between frontotemporal dementia and Alzheimer's disease: a review.

Authors:  Michal Harciarek; Krzysztof Jodzio
Journal:  Neuropsychol Rev       Date:  2005-09       Impact factor: 7.444

2.  Mapping the effect of APOE epsilon4 on gray matter loss in Alzheimer's disease in vivo.

Authors:  M Pievani; P E Rasser; S Galluzzi; L Benussi; R Ghidoni; F Sabattoli; M Bonetti; G Binetti; P M Thompson; G B Frisoni
Journal:  Neuroimage       Date:  2009-01-21       Impact factor: 6.556

3.  A Meta-Analysis of Alzheimer's Disease Incidence and Prevalence Comparing African-Americans and Caucasians.

Authors:  Kyle Steenland; Felicia C Goldstein; Allan Levey; Whitney Wharton
Journal:  J Alzheimers Dis       Date:  2016       Impact factor: 4.472

4.  Variation at APOE and STH loci and Alzheimer's disease.

Authors:  Lingjun Zuo; Christopher H van Dyck; Xingguang Luo; Henry R Kranzler; Bao-zhu Yang; Joel Gelernter
Journal:  Behav Brain Funct       Date:  2006-04-07       Impact factor: 3.759

5.  Examination of candidate exonic variants for association to Alzheimer disease in the Amish.

Authors:  Laura N D'Aoust; Anna C Cummings; Renee Laux; Denise Fuzzell; Laura Caywood; Lori Reinhart-Mercer; William K Scott; Margaret A Pericak-Vance; Jonathan L Haines
Journal:  PLoS One       Date:  2015-02-10       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.